Experimental stem cell therapy tested for deadly transplant complication
NCT ID NCT03158896
Summary
This early-stage study tested the safety of stem cells from umbilical cords for treating severe graft-versus-host disease (GVHD), a dangerous complication that can occur after a bone marrow transplant. The study involved 24 adults who developed severe GVHD that didn't respond to standard steroid treatment. Researchers gave participants one of two dose levels of these special stem cells to see if they were safe and might help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE GRAFT VERSUS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kansas University Cancer Center
Kansas City, Kansas, 66160, United States
Conditions
Explore the condition pages connected to this study.